Skip to main content

Table 4 Median survival time, cumulative survival probability, significance and log rank test of cervical cancer patients at Tikur Anbesa Specialized Hospital oncology center, Ethiopia (n = 634)

From: Survival status and associated factors of death among cervical cancer patients attending at Tikur Anbesa Specialized Hospital, Addis Ababa, Ethiopia: a retrospective cohort study

Covariates

Median survival time, In month (95% CL)

Overall 5-year Survival (%)

Log rank test

p–value

Age

  

39.87

< 0.001

  < 30

a

81.45

 30–39

a

56.51

 40–49

39 (31.93–43.3)

41.42

 50–59

32.2 (27.37–38.46)

21.29

  ≥ 60

30.37 (26.07–35)

22.30

Substance

  

10.63

0.0011

 User

32.2 (20.5–37.77)

31.57

 None User

38.46 (35.93–47.7)

39.62

FIGO Stage

  

56.68

< 0.001

 I

a

81.04

 II

a

67.94

 III

35 (30.37–37.87)

23.33

 IV

28.87 (21.6–34.37)

20.03

Anemic Status

  

27.05

< 0.001

 Yes

31.4 (28.87–36.53)

30.26

 No

a

55.05

Comorbidity

  

27.78

< 0.001

 Yes

29.8 (26.33–33.17)

21.55

 No

 

51.80

Aim RT

  

21.05

< 0.001

 Radical

46.53 (34.4–51.52)

46.16

 Palliative

34.67 (30.03–37.3)

32.57

 No RT

a

82.8

  1. avalues that hadn’t median survival from the specific categorical variable